Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Report
  • Published:

Analysis of genetic and epigenetic processes that influence p14ARF expression in breast cancer

Abstract

The INK4a/ARF locus encodes two unrelated cell cycle-regulatory proteins that both function in tumor suppression, p16INK4a and p14ARF. In human tumors including breast cancer, alterations affecting selectively p14ARF have been poorly analysed. We have performed a comprehensive analysis of the inactivation mechanisms (mutation, homozygous and hemizygous deletion, and promoter hypermethylation) in a large series of 100 primary breast carcinomas. RT–PCR showed expression variable of the p14ARF transcript, with 17% demonstrating overexpression and 26% demonstrating decreased expression. No detectable alterations were observed in the majority of cases with overexpressed p14ARF mRNA, but 77% of tumors with decreased expression presented at least one of these genetic/epigenetic alterations. Nevertheless, a statistically significant correlation was observed between decreased p14ARF expression and several poor prognostic parameters.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  • Brenner AJ, Paladugu A, Wang H, Olopade OI, Dreyling MH, Aldaz CM . 1996 Clin. Cancer Res. 2: 1993–1998

  • Chin L, Pomerantz J, DePinho RA . 1998 Trends Biochem. Sci. 23: 291–296

  • Esteller M, Tortola S, Toyota M, Capella G, Peinado MA, Baylin SB, Herman JG . 2000 Cancer Res. 60: 129–133

  • Fitzgerald MG, Harkin DP, Silva-Arrieta S, MacDonald DJ, Lucchina LC, Unsal H, O'Neill E, Koh J, Finkelstein DM, Isselbacher KJ, Sober AJ, Haber DA . 1996 Proc. Natl. Acad. Sci. USA 93: 8541–8545

  • Gazzeri S, Della Valle V, Chaussade L, Brambilla C, Larsen CJ, Brambilla E . 1998 Cancer Res. 58: 3926–3931

  • Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB . 1996 Proc. Natl. Acad. Sci. USA 93: 9821–9826

  • Herranz M, Urioste M, Santos J, Rivas C, Martinez B, Benitez J, Fernandez-Piqueras J . 1999 Leukemia 13: 808–810

  • Iida S, Akiyama Y, Nakajima T, Ichikawa W, Nihei Z, Sugihara K, Yuasa Y . 2000 Int. J. Cancer 87: 654–658

  • Iwato M, Tachibana O, Tohma Y, Arakawa Y, Nitta H, Hasegawa M, Yamashita J, Hayashi Y . 2000 Cancer Res. 60: 2113–2115

  • Kamijo T, Zindy F, Roussel MF, Quelle DQ, Downing JR, Ashmun RA, Grosveld G, Sherr CJ . 1997 Cell 91: 649–659

  • Kumar R, Sauroja I, Punnonen K, Jansen C, Hemminki K . 1998 Gene. Chromosome. Canc. 23: 273–277

  • Liggett WH, Sidransky D . 1998 J. Clin. Oncol. 16: 1197–1206

  • Markl IDC, Jones PA . 1998 Cancer Res. 58: 5348–5353

  • Oto M, Miyake S, Yuasa Y . 1993 Ann. Biochem. 213: 19–22

  • Quelle DE, Zindy F, Ashmun RA, Sherr CJ . 1995 Cell 83: 993–100

  • Quelle DE, Cheng M, Ashmun RA, Sherr CJ . 1997 Proc. Natl. Acad. Sci. USA 94: 669–673

  • Robertson KD, Jones PA . 1998 Mol. Cell. Biol. 18: 6457–6473

  • Sanchez-Céspedes M, Reed AL, Buta M, Wu L, Westra WH, Herman JG, Yang SC, Jen J, Sidransky D . 1999 Oncogene 18: 5843–5849

  • Serrano M, Hannon GJ, Beach D . 1993 Nature 366: 704–707

  • Stone S, Jiang P, Dayananth P, Tavtigian SV, Katcher H, Parry D, Peters G, Kamb A . 1995 Cancer Res. 55: 2988–2994

  • Takemoto S, Trovato R, Cereseto A, Nicot C, Kislyakova T, Casareto L, Waldmann T, Torelli G, Franchini G . 2000 Blood 95: 3939–3944

  • Tao W, Levine AJ . 1999 Proc. Natl. Acad. Sci. USA 96: 6937–6941

  • Vonlanthen S, Heighway J, Tschan MP, Borner MM, Altermatt HJ, Kappeler A, Tobler A, Fey MF, Thatcher N, Yarbrough WG, Betticher DC . 1998 Oncogene 17: 2779–2785

  • Zhang Y, Xiong Y, Yarbrough WG . 1998 Cell 92: 725–734

  • Zheng S, Chen P, McMillan A, Lafuente A, Lafuente MJ, Ballesta A, Trias M, Wiencke JK . 2000 Carcinogenesis 21: 2057–2064

  • Zindy F, Eischen CM, Randle D, Kamijo T, Cleveland JL, Sherr CJ, Roussel MF . 1998 Genes Dev. 12: 2424–2434

Download references

Acknowledgements

We are grateful to Mr Robin Rycroft for his assistance with the English language, revision and preparation of the manuscript. This work was supported by grants from the Fundación Banco Santander Central Hispano, Aventis Pharma S.A and CAM 08.1/0069/20002.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Silva, J., Domínguez, G., Silva, J. et al. Analysis of genetic and epigenetic processes that influence p14ARF expression in breast cancer. Oncogene 20, 4586–4590 (2001). https://doi.org/10.1038/sj.onc.1204617

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204617

Keywords

This article is cited by

Search

Quick links